Tehran University of Medical Sciences International Journal of Hematology-Oncology and Stem Cell Research 2008-2207 20 1 2026 02 09 78 96 Mohammad Jahangiri Iranian Cancer Control Center,Tehran, Iran Suzanne Hojjat-Assari French Institute of Research and High Education, Paris, France Pooneh Pirjani Iranian Cancer Control Center,Tehran, Iran Mohammad Vaezi Hematology, Oncology, and Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology, and Cell Therapy, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran Ghasem Janbabaei Hematologic Malignancies Research Center, Research Institute for Oncology, Hematology and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran Shayesteh Kokabi Hamidpour Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical sciences, Tehran, Iran Nafiseh Heidarzadeh Isfahani Iranian Cancer Control Center, Isfahan, Iran Babak Arjmand Hematology, Oncology, and Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology, and Cell Therapy, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran 2025 05 03 2026 01 04 Integrating supportive and palliative care into the oncology program is considered essential for effective cancer management. Despite the challenges that low- and middle-income countries such as Iran face in providing comprehensive supportive and palliative care services, continuous efforts are directed towards improving services and infrastructure. In this regard, the Iranian Cancer Control Center (MACSA) plays a fundamental role in providing supportive and palliative care with special emphasis on expanding services and ensuring equitable access for cancer patients in Iran. Through joint efforts with various organizations and hospitals, coupled with the implementation of effective leadership strategies, MACSA has tried to integrate its services into a referral hospital system in order to continuously improve and expand services and meet the multifaceted needs of patients and families affected by cancer. Indeed, MACSA's initiatives to embed supportive and palliative care within the framework of usual care in referral hospitals are critical in improving outcomes and quality of life for people battling cancer. The interdisciplinary nature of supportive and palliative care, involving a specialized team, is essential for efficient service delivery, cost-effectiveness, and overall quality of care. https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/2445 https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/download/2445/1121